Syndecan-1 expression in prostate cancer and its value as biomarker for disease progression.

@article{Brimo2010Syndecan1EI,
  title={Syndecan-1 expression in prostate cancer and its value as biomarker for disease progression.},
  author={Fadi Brimo and Robin T. Vollmer and Matthew Friszt and Jacques Corcos and Tarek A. Bismar},
  journal={BJU international},
  year={2010},
  volume={106 3},
  pages={418-23}
}
OBJECTIVE To evaluate the association between syndecan-1 (CD138) expression and prostate cancer. PATIENTS AND METHODS We evaluated syndecan-1 expression using a recently constructed tissue microarray of prostatic samples taken from 243 patients, corresponding to 1400 cores, with 69.8%, 5.6%, 17.6% and 7% of the cores representing localized prostate cancer, high-grade prostatic intraepithelial neoplasia, benign prostate tissue and hormone refractory/metastatic disease, respectively. RESULTS… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 30 references

Expression of syndecan

  • CL Chen, DL Ou
  • 2005

Altered expression of syndecan1 in prostate cancer

  • J Kiviniemi, M Kallajoki
  • APMIS
  • 2004

Similar Papers

Loading similar papers…